Navigation Links
Augmenix, Inc. Closes $6.1 Million Financing
Date:10/16/2009

lthventures.org) was launched in 2001 as a wholly-owned subsidiary of Ascension Health. AHV's role has been to construct and manage a strategic portfolio of investments that deliver a venture investment return, have the potential to transform the healthcare industry and significantly enhance the quality of patient care. CHV II, LP, a limited partnership between Ascension Health, Catholic Health Initiatives, Catholic Health East and Catholic Healthcare West, has been formed to expand this strategic investment initiative to other Catholic healthcare systems. AHV is the general partner of CHV II, LP.

SOURCE Augmenix, Inc.


'/>"/>
SOURCE Augmenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Beckman Coulter Announces Third Quarter 2009 Earnings to be Released on Thursday, October 29, 2009, After Market Closes
2. Archi-Tech Closes the Gap Between Pharmaceutical Managed Care and Primary Sales with Pull-Through Reporting Capabilities
3. Greenway Medical Technologies Closes 11th Consecutive Fiscal Year of Positive Growth
4. AdvanDx Closes $8 Million Financing Round and Elects New Board Member
5. HeartWare International, Inc. Closes US$60 Million Financing
6. Emdeon Closes The Sentinel Group Acquisition, Implements First Customer in Less than 30 Days
7. Croff Enterprises, Inc. Closes Merger and Will Change Name to Americas Minority Health Network, Inc.
8. Paradigm Spine Closes $21.5 Million Financing and Announces Promotion of Matt Stuttle to Position of Vice President, US Sales
9. Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery
10. Providence Service Corporation to Report Second Quarter 2009 Results on Monday, August 10th After the Market Closes
11. SecureWorks Closes Acquisition of VeriSigns Managed Security Services Business

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ALLEY, Pa., Dec. 1 Air P... the previously announced sale of the assets of it...er the Airthane® and Versathane® tradena...global polyurethane chemicals producer COIM SpA. ...acturing facility in Paulsboro, N.J. Terms of the ...
(Date:12/1/2009)...TON, Dec. 1 Individuals...likely than those with traditional coverage to exh...ore engaged in wellness programs, and to be more i...in holding down costs, according to survey results...t Research Institute (EBRI). ,, At the same ti...
(Date:12/1/2009)...IX, Dec. 1 Abrazo Media Relations-...sis ( http:// www.pedsorthopaedics.com ) located i...dic surgeon Dr. J. Hunt Udall to its practice. ,...thopaedic surgery after recently completing his fe... Massachusetts where he focused on adult and pedia...
(Date:12/1/2009)...AUDERDALE, Fla., Dec. 1 OrbusNeich...ent in the randomized clinical trial of the Combo ...t). ,, A prospective, randomized, multicenter s... ablu M inal sirolimus coat ED bio- E ngine...20 sites in Asia, Australia, Europe and South Amer...
(Date:12/1/2009)... The ADEAGies Foundation will honor The Forsyth I...the Gies Awards celebration to be held on February...the 2010 ADEA Annual Session & Exhibition. The Wil...hievement recognize contributions to, and support ...or a complete listing of Gies Award winners, visit...
Breaking Medicine News(10 mins):Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2
...inal Imaging System Allows Primary Care Physicians...l Images, WAKE FOREST, N.C., Sept. 19 Digital He...se management company based in Wake,Forest, NC, an...(R) technology platform. Retasure is a simple, af...
...IEW, Calif., Sept. 20 Cardiva Medical, Inc.,a pri...y that Augustine,Lien, Chairman and CEO, will pres... on Tuesday, September 25th in New York City. Nota...arket,clearance. This new product builds on the su...
...s Position as the Global Leader in Endoscopic Anti...Surgical, Inc. (NDO),announced that the US Food an...Plicator II(TM) multiple implant technology for im...This clearance and the subsequent launch of next-g...
...., Sept. 21 Cephalon, Inc. (Nasdaq:,CEPH) today a...ion (NDA) to,the U.S. Food and Drug Administration...tine HCl) for the treatment of patients with chron...e United States, according to the National Cancer ...
...) receives FDA clearance, REDMOND, Wash., Sept. 2...X(TM) device for performing Transoral Incisionless...troesophageal reflux,disease has received FDA clea...yesterday under general anesthesia,transoral, inci...
...IV Prof. Ehud Assia, of Tel Aviv Universitys Sack...ar in the field of eye surgery. , One of a small ...orm a complicated form of glaucoma surgery, Prof. ... give most practicing eye surgeons the ability to ...
Other Medicine News:Health News:Digital Healthcare Wins FDA Approval for Retasure 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:NDO Receives FDA 510(K) Clearance for Plicator II(TM) 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 3Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 4Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 2Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 3Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 4Health News:Glaucoma surgery in the blink of an eye 2
(Date:12/1/2009)... Sagent Pharmaceuticals, Inc., a p...day announced the launch of two antibiotics: cefox...ion, USP. Both are antibiotics of the cephalospori...nd gram-negative bacteria. Sagent will launch ceft...he four vial sizes launched by Sagent in July 2008...
(Date:12/1/2009)...c. 1 The global financial crisis, ...an industry experiencing significant change, and r...rive up the effective tax rate for the pharmace... report released today by PricewaterhouseCoopers e...ath will you take? The industry,s response to the...
(Date:11/30/2009)... 30 Microban International, Ltd., ...t protection, is pleased to announce their exclusi...the largest U.S. manufacturer and distributor of c...aunching two new lines of ceramic tile with OutSta...t pending silver based technology, in order to cre...
Breaking Medicine Technology:Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 5Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Recruitment of reproductive features into other cell types may underlie extended lifespan in animals 8735 1Recruitment of reproductive features into other cell types may underlie extended lifespan in animals 8735 2Summer Fun Need Not Be Hazardous 48109 1Summer Fun Need Not Be Hazardous 48109 22009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 48105 12009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 48105 22009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 48105 3
... Prior to Surgery, ARLINGTON HEIGHTS, Ill., Nov. ...sive weight loss patients seeking body,contouring ..., accelerate,wound healing, improve scar quality a...y in the December issue of Plastic and Reconstruct...e American Society of Plastic,Surgeons (ASPS). Opt...
... in this Friday,s online edition of Cell will help...ase?, One of the most pressing questions in the m...auses the sensitive cells in the brain to die,in t...specially difficult,because there are two nearly i...e and they are mixed together in the same brain re...
Other Medicine Technology:Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2A Window Into Parkinson's Disease 2
... is the only HER-2 assessment test approved by the...claims: prognosis, adriamycin-based chemotherapy s...al antibody therapy selection. PathVysion is the o...Herceptin® package insert as an appropriate te...
...op® medication nebulizer achieves optimum lung...mented MMAD particle size range is 1.04-1.10 &micr...compressor or air outlet., ,As the world leader i...care providers the assurance of proven technology ...
CK1001 Small Volume Medication Kits
6075-504 Custom Nebulizer Kit
Medicine Products: